France· FR:60443413
TORISEL 30 mg, solution à diluer et solvant pour solution pour perfusion
A medicinal product containing temsirolimus, registered in France by PFIZER EUROPE MA EEIG (BELGIQUE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TEMSIROLIMUS
- Manufacturer
- PFIZER EUROPE MA EEIG (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009571783761 flacon(s) en verre de 1,2 ml - 1 flacon(s) en verre de 1,8 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Temsirolimus in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainTEMSIROLIMUS ACCORD 30 MG CONCENTRADO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- BelgiumTemsirolimus Accord 30 mgAccord Healthcare
- CzechiaTORISELPfizer Europe MA EEIG, Bruxelles
- FinlandToriselPfizer Europe MA EEIG
- United KingdomTorisel 30mg/1.2ml concentrate for solution for infusion vials and diluentPfizer Ltd
- IrelandTorisel 30 mg concentrate and solvent for solution for infusionPfizer Europe MA EEIG
- IcelandToriselPfizer Europe MA EEIG*
- NetherlandsTorisel 25 mg/ml, concentraat voor oplossing voor infusiePfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Croatia · Temsirolimus Accord
- Iceland · Torisel
- Liechtenstein · Torisel
- Norway · Torisel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b601d2b7-ea90-4a1d-bba7-96ce1e37e5d2 GET /v1/drugs/b601d2b7-ea90-4a1d-bba7-96ce1e37e5d2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60443413",
"date_amm": "2007-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/07/424",
"substance": "TEMSIROLIMUS",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer et solvant pour solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about temsirolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.